Search research articles
Contact Us
Filters
Showing results (1-10 of 190) with videos related to
Page
of 19
Sort By:
Clinical Pharmacology and Therapeutics
|
September 12, 2019
Who Believes They Are "Just Average": Informing the Treatment of Individual Patients Using Population Data
J Steven Leeder
Clinical Pharmacology and Therapeutics
|
February 12, 2015
Meaningful use and clinical utility of preemptive pharmacogenetic testing: (re)view from a CYP2D6 poor metabolizer
J Steven Leeder
Pharmacogenomics
|
April 30, 2003
Developmental and pediatric pharmacogenomics
J Steven Leeder
Drug Discovery Today
|
June 19, 2004
Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond
J Steven Leeder
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
January 10, 2022
Ontogeny of Pediatric Pharmacogenetics: Celebrating the Past and Vision for the Future
J Steven Leeder
Paediatric Anaesthesia
|
January 10, 2003
Cytochrome P450 pharmacogenetics and anaesthesia
Christian Seefelder, J Steven Leeder
Pharmacogenomics
|
October 19, 2018
Pharmacogenomics and implementation of precision therapeutics in the neonatal ICU: a new frontier?
Tamorah Lewis, J Steven Leeder
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 16, 2016
Challenges and Opportunities for Increasing the Knowledge Base Related to Drug Biotransformation and Pharmacokinetics during Growth and Development
J Steven Leeder, Bernd Meibohm
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 24, 2006
Comments on Hoskins et al. [(2005) drug metab dispos 33:1564-1565]
Andrea Gaedigk, J Steven Leeder
Pharmacogenomics
|
March 15, 2014
CYP2D6 and pharmacogenomics: where does future research need to focus? Part 1: technical aspects
Andrea Gaedigk, J Steven Leeder
Page
of 19
Search research articles
Search
Showing results (1-10 of 190) with videos related to
Sort By:
Page
of 19
Clinical Pharmacology and Therapeutics
|
September 12, 2019
Who Believes They Are "Just Average": Informing the Treatment of Individual Patients Using Population Data
J Steven Leeder
Clinical Pharmacology and Therapeutics
|
February 12, 2015
Meaningful use and clinical utility of preemptive pharmacogenetic testing: (re)view from a CYP2D6 poor metabolizer
J Steven Leeder
Pharmacogenomics
|
April 30, 2003
Developmental and pediatric pharmacogenomics
J Steven Leeder
Drug Discovery Today
|
June 19, 2004
Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond
J Steven Leeder
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
January 10, 2022
Ontogeny of Pediatric Pharmacogenetics: Celebrating the Past and Vision for the Future
J Steven Leeder
Paediatric Anaesthesia
|
January 10, 2003
Cytochrome P450 pharmacogenetics and anaesthesia
Christian Seefelder, J Steven Leeder
Pharmacogenomics
|
October 19, 2018
Pharmacogenomics and implementation of precision therapeutics in the neonatal ICU: a new frontier?
Tamorah Lewis, J Steven Leeder
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 16, 2016
Challenges and Opportunities for Increasing the Knowledge Base Related to Drug Biotransformation and Pharmacokinetics during Growth and Development
J Steven Leeder, Bernd Meibohm
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 24, 2006
Comments on Hoskins et al. [(2005) drug metab dispos 33:1564-1565]
Andrea Gaedigk, J Steven Leeder
Pharmacogenomics
|
March 15, 2014
CYP2D6 and pharmacogenomics: where does future research need to focus? Part 1: technical aspects
Andrea Gaedigk, J Steven Leeder
Page
of 19